It has been standard teaching for many years that opiates should not in any circumstances be given to dyspnoeic patients with chronic bronchitis, but the evidence on which this view is based is derived almost solely from clinical impressions. Although morphine and its derivatives have been shown to diminish the ventilatory response to carbon dioxide in normal human volunteers (Loeschcke, Sweel, Kough, and Lambertsen, 1953) , there have been virtually no scientifically controlled observations on the effect of opiates in patients with ventilatory failure complicating chronic bronchitis and emphysema.
Attempts have been made in such patients to study retrospectively the effect of opiates on respiration by observing the changes which occur in minute volume and in the carbon dioxide tension, oxygen saturation, and pH of arterial blood during recovery from injections of morphine. In one such study on five patients with severe emphysema (Wilson, Hoseth, and Dempsey, 1954) these measurements were made 'during narcosis' after the injection of 15 mg. morphine, and 'on recovery'. Since the morphine had been administered (on incorrect indications) before the patients were admitted to hospital in ventilatory failure, and no precise time relationships are given, it cannot be assumed that the severe hypercapnia, hypoxaemia, and respiratory acidosis which were found on analysis of arterial blood samples taken 'during narcosis' were solely due to the central action of morphine on respiration, since they may have been partly or even mainly due to secondary effects such as bronchial obstruction by secretions.
The authors based their conclusion that morphine caused central depression of respiration on the observation that the figures for arterial carbon dioxide tension, pH, and oxygen saturation and for respiratory minute volume improved significantly 'on recovery from sedation'. This conclusion seems to be inadmissible because the time interval between the withdrawal of the two arterial samples was not stated, and because precise details of the treatment the patients had received during this period were not given. Even a few effective coughs could, by clearing the airways, have produced a marked reduction in the degree of hypercapnia and hypoxaemia, and the administration of respiratory stimulants, which, according to the text, some patients may have received, would totally invalidate the results of the investigation.
Our interest in the subject was aroused by the difficulty we experienced in relieving intense dyspnoea in patients with chronic bronchitis and emphysema who had reached the terminal stages of chronic ventilatory failure. In one particular patient, whose respiratory distress was such that he repeatedly expressed a desire to die, we considered it would be justifiable to give an opiate as a last resort, and we observed the effect of the drug on the arterial blood gas status. The arterial oxygen saturation (Sao2), estimated on each occasion while the patient was breathing oxygen from a Venturi mask at the 25% gauge setting, had for several weeks fluctuated between 75% and 85%', and the arterial carbon dioxide tension (Paco2) had varied between 90 mm. Hg and 100 mm. Hg, but the arterial pH had remained within the normal range. It was decided to give him in the first instance a very small dose of opiate (papaveretum, 10 mg. subcutaneously), and to increase the dose only if this did not produce any alarming change in his clinical state or in his arterial blood gas status. The patient claimed that after the injection he was able to breathe more comfortably, and his respiratory efforts seemed less laboured. This effect was augmented when he was given 20 mg. papaveretum on two subsequent occasions, but he became relaxed and slightly drowsy with the higher dose.
Samples of arterial blood were withdrawn immediately before each injection and again 90 minutes later. The As a result of these exclusions the study was confined to those in a relatively stable state as far as their arterial blood gases were concerned, but 4 the actual degree of ventilatory failure, as judged by the level of Sao2 and Paco2, did not influence the selection. In order to increase the number of subjects with normal arterial blood gases wẽ -°included bronchitic patients who were being given papaveretum as premedication for bronchoscopy, the studies being completed before the introducs90 minutes tion of the bronchoscope. Some of these patients were given scopolamine (0-4 mg.) together with in papaveretum (20 mg.) to tolerate the face-piece. Complete data for VE were thus obtained in 21 of the 24 studies with papaveretum alone in addition to all three of the studies with papaveretum and scopolamine.
In all but two of the studies, to which reference will later be made, the patients were breathing air throughout the period of observation.
The samples of arterial blood were examined by the following techniques within a few minutes of withdrawal: ARTERIAL OXYGEN SATURATION Measured by means of a Kipp Brinkman Haemoreflector (Zijlstra, 1953 (Campbell, 1962) . Table I summarizes the results obtained from arterial blood gas analysis and minute volume estimations before the injection of papaveretum. Figure 2 . In Table II the results are given for It is clear, both on statistical grounds and from a study of individual patients, that there is a difference in magnitude between the effect of decreased pulmonary ventilation on Paco2 and its effect on Sao2. In the series as a whole, the reduction in Sao2 achieves a higher degree of statistical significance than the increase in Paco2. Furthermore, when the results are analysed according to the initial level of Paco2, by which the patients are separated into groups with normocapnia, moderate hypercapnia, and severe hypercapnia, the increase in Paco2 is not statistically significant at the 5% level in any group, whereas the reduction in Sao2 is highly significant in the groups with moderate hypercapnia (P<001) and severe hypercapnia (P<0-02) and almost significant at the 5% level in the normocapnic group. An analysis of the response of individual patients in this series shows that the Paco2 increased in only 58 %, whereas the Sao2 decreased in 75%. If only hypercapnic patients are considered, the figures are 62%o/ and 87% respectively. The differing relation between Sao2 and VE on the one hand, and between Paco2 and VE on the other, is shown in Fig. 3 , where it can be seen that a reduction in VE was associated with a fall in Sao2 in 15 of the 21 studies in which both measurements were recorded, but with a rise in Paco2 in only 10 studies. In chronic ventilatory failure the hypoxaemia may not be associated with a commensurate increase in Paco2. The usual explanation for this is that the hypoxaemia is produced by a disturbance of the relation between ventilation and blood flow in individual alveoli or groups of alveoli, and that hyperventilation of normally functioning alveoli in response to the stimuli of hypercapnia and hypoxia prevents any great increase in Paco2 but cannot correct to any significant degree the reduction in Sao2. The results of this investigation suggest that the administration of an opiate to patients with chronic bronchitis not only reduces total alveolar ventilation but also, and to a relatively greater degree, reduces the alveolar ventilation: blood flow ratio. It is possible that a reduction in the total alveolar ventilation may cause a differential reduction in the ventilation of certain groups of alveoli and in that way reduce the overall ventilation: blood flow ratio to a degree proportionately in excess of the reduction in total alveolar ventilation. On the other hand, reduction in the ventilation: blood flow ratio might be caused by increased perfusion of underventilated alveoli, resulting from the direct action of papaveretum on the pulmonary vasculature. Provided any reduction in the ventilation: blood flow ratio produced in either of these ways is not completely offset by a proportionate reduction in total alveolar ventilation, the outcome will be a fall in Sao2 associated with a proportionately smaller rise in Paco2 or, in some cases, no rise at all. These theories are highly speculative, and there may be other more acceptable explanations for this phenomenon. Nevertheless, it seems likely that the effect of opiates on respiration involves processes much more complex than a simple reduction in pulmonary ventilation caused by depression either of the intrinsic activity of the respiratory centre or of its sensitivity to changes in arterial blood gas tensions. To elucidate these processes is a formidable task which will involve, in addition to *the measurement of arterial blood gas tensions, the estimation of ventilation: blood flow ratios, 'transfer factor', pulmonary blood flow, and pulmonary vascular resistance before and after administration of the drug.
RESULTS
The rise in Paco2 after the injection of papaveretum, except in a few cases, was relatively slight, and the resulting degree of respiratory (1942) , who in normal subjects found that the depression of minute volume by morphine was counteracted by scopolamine. It may be that the effect of these drugs on respiration in patients with chronic bronchitis differs from their effect on normal subjects. This is a point which may be of practical importance when premedication is prescribed for patients with chronic respiratory disease and one which deserves further study.
SUMMARY
The effect of opiates on patients with chronic bronchitis was studied before and 60 minutes after a subcutaneous injection of papaveretum (20 mg.) by measuring arterial oxygen saturation (Sao2), carbon dioxide tension (Paco2), pH, plasma bicarbonate, and the minute volume of pulmonary ventilation (VE).
Twenty-four studies were performed on 22 patients. Before the injection was given the Paco2 was below the accepted upper limit of normal (47 mm. Hg) in eight patients: in the other 16, all with stabilized chronic ventilatory failure, the Paco2 ranged between 47 mm. Hg and 98 mm. Hg. Except in two patients, the arterial pH was normal, since it was not considered advisable to administer an opiate to patients with uncompensated respiratory acidosis.
The most common pattern of response to papaveretum was a reduction in VE and Sao2, an increase in Paco2, and a slight fall in pH, which had not (after 60 minutes) been corrected by an increase in plasma bicarbonate.
The reduction in Sao2 was proportionately greater than the increase in Paco2. The possible reasons for this are discussed.
The amount by which the Paco2 increased after the injection of papaveretum did not appear to be related to the degree of ventilatory failure, but greater reductions in Sao2 were recorded in hypercapnic than in normocapnic subjects.
As hypoxaemia, often of a serious degree, is invariably present in hypercapnic patients, the
